gracillin has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayet, C; Darbour, N; Di Pietro, A; Dijoux-Franca, MG; Doreau, A; Dumontet, C; Guilet, D; Nguyen, VT; Phung, BH; Raad, I | 1 |
| Hu, K; Yao, X | 1 |
2 other study(ies) available for gracillin and Leukemia
| Article | Year |
|---|---|
Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cyclosporine; Daunorubicin; Diosgenin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ecdysteroids; Ecdysterone; Humans; Immunosuppressive Agents; K562 Cells; Leukemia; Magnoliopsida; Membrane Transport Modulators; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Plant Extracts; Rhizome; Saponins; Spirostans; Steroids | 2009 |
The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Central Nervous System Neoplasms; Colonic Neoplasms; Dioscorea; Dose-Response Relationship, Drug; Female; Humans; Kidney Neoplasms; Lethal Dose 50; Leukemia; Male; Melanoma; Mice; Phytotherapy; Plant Extracts; Plant Roots; Prostatic Neoplasms; Saponins; Spirostans; Steroids; Tumor Cells, Cultured | 2003 |